These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23573544)

  • 61. Atovaquone and proguanil versus amodiaquine for the treatment of Plasmodium falciparum malaria in African infants and young children.
    Borrmann S; Faucher JF; Bagaphou T; Missinou MA; Binder RK; Pabisch S; Rezbach P; Matsiegui PB; Lell B; Miller G; Kremsner PG
    Clin Infect Dis; 2003 Dec; 37(11):1441-7. PubMed ID: 14614665
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Artemisinin-based combination therapy (ACT) versus atovaquone-proguanil: do not choose between but, rather, combine them.
    Schwartz E; Lachish T
    Evid Based Med; 2016 Apr; 21(2):64. PubMed ID: 26759150
    [No Abstract]   [Full Text] [Related]  

  • 63. 39-Year-Old Woman With Headache and Fever.
    Matcha GV; Steele HP; Harris DM
    Mayo Clin Proc; 2015 Nov; 90(11):e119-23. PubMed ID: 26541259
    [No Abstract]   [Full Text] [Related]  

  • 64. Prophylactic drugs for malaria: why do we need another one?
    Kain KC
    J Travel Med; 1999 May; 6 Suppl 1():S2-7. PubMed ID: 23573545
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [symbol: see text] Atovaquone + proguanil for malaria prophylaxis.
    Drug Ther Bull; 2001 Oct; 39(10):73-5. PubMed ID: 11706518
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Discontinuing atovaquone/proguanil prophylaxis ad-hoc post-exposure and during-travel dose-sparing prophylactic regimens against P. falciparum malaria: An update with pointers for future research.
    Schnyder JL; de Jong HK; Schlagenhauf P; Borrmann S; Hanscheid T; Grobusch MP
    Travel Med Infect Dis; 2022; 49():102365. PubMed ID: 35661741
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa.
    Kuhn S; Gill MJ; Kain KC
    Am J Trop Med Hyg; 2005 Apr; 72(4):407-9. PubMed ID: 15827276
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Analyses of cytochrome b mutations in Plasmodium falciparum isolates in Thai-Myanmar border.
    Naoshima-Ishibashi Y; Iwagami M; Kawazu S; Looareesuwan S; Kano S
    Travel Med Infect Dis; 2007 Mar; 5(2):132-4. PubMed ID: 17298921
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Short report: no evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate.
    Gupta RK; Van Vugt M; Paiphun L; Slight T; Looareesuwan S; White NJ; Nosten F
    Am J Trop Med Hyg; 2005 Aug; 73(2):267-8. PubMed ID: 16103586
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines.
    Bustos DG; Canfield CJ; Canete-Miguel E; Hutchinson DB
    J Infect Dis; 1999 Jun; 179(6):1587-90. PubMed ID: 10228090
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Parallel evolution of adaptive mutations in Plasmodium falciparum mitochondrial DNA during atovaquone-proguanil treatment.
    Musset L; Le Bras J; Clain J
    Mol Biol Evol; 2007 Aug; 24(8):1582-5. PubMed ID: 17488741
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Delivery of atovaquone and proguanil across sublingual membranes, in vitro.
    Wallace E; Ong CM; Heard CM
    Pharm Dev Technol; 2012; 17(6):770-6. PubMed ID: 21612571
    [TBL] [Abstract][Full Text] [Related]  

  • 73. "Collateral" effect of artemether in an atypical kidney involvement by Plasmodium falciparum malaria: a case report.
    Calitri C; Garazzino S; Camilla R; Peruzzi L; Amore A; Tovo PA
    J Vector Borne Dis; 2014 Jun; 51(2):147-8. PubMed ID: 24947225
    [No Abstract]   [Full Text] [Related]  

  • 74. In vitro recrudescence of Plasmodium falciparum parasites suppressed to dormant state by atovaquone alone and in combination with proguanil.
    Thapar MM; Gil JP; Björkman A
    Trans R Soc Trop Med Hyg; 2005 Jan; 99(1):62-70. PubMed ID: 15550263
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Further observation of travellers taking twice-weekly atovaquone-proguanil prophylaxis in sub-Saharan Africa.
    Biber A; Harel R; Schwartz E
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30690466
    [No Abstract]   [Full Text] [Related]  

  • 76. Proguanil and atovaquone use is associated with lower colorectal cancer risk: a nationwide cohort study.
    Zhang N; Sundquist J; Sundquist K; Ji J
    BMC Med; 2022 Nov; 20(1):439. PubMed ID: 36357883
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Atovaquone-proguanil for prophylaxis and treatment of malaria.
    Marra F; Salzman JR; Ensom MH
    Ann Pharmacother; 2003 Sep; 37(9):1266-75. PubMed ID: 12921511
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens.
    Kain KC; Shanks GD; Keystone JS
    Clin Infect Dis; 2001 Jul; 33(2):226-34. PubMed ID: 11418883
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Creating and Validating Ligase Primers to Detect Single Nucleotide Polymorphisms Associated with Atovaquone Resistance in Plasmodium falciparum.
    Alruwaili M; Elahi R; van Schalkwyk D; Sutherland C; Shapiro T; Prigge S; Sullivan D
    Am J Trop Med Hyg; 2023 Apr; 108(4):777-782. PubMed ID: 36878214
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Plasmodium falciparum malaria associated with mefloquine failure in Gambia.
    Callen EC; Church CO
    Pharmacotherapy; 2006 Oct; 26(10):1526-8. PubMed ID: 16999663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.